Related Experiment Videos
Sea-blue histiocytosis associated with hyperlipidaemia
Journal of Clinical Pathology
|July 1, 1976
Summary
Sea-blue histiocytosis, a rare condition, may indicate abnormal lipid metabolism. This case study highlights a patient with hyperlipidemia linked to cholesterol and triglyceride issues, suggesting a transport defect.
Area of Science:
- Hematology
- Biochemistry
- Lipid Metabolism
Background:
- Sea-blue histiocyte (SBH) is a distinctive morphological finding in bone marrow and spleen.
- Hyperlipidemia is a condition characterized by elevated levels of lipids in the blood.
Observation:
- A patient presented with sea-blue histiocytosis in the spleen and bone marrow.
- The patient also exhibited hyperlipidemia, specifically elevated free cholesterol, lecithin, and triglycerides.
Findings:
- Lecithin-cholesterol acyl transferase (LCAT) activity was normal despite the observed hyperlipidemia.
- In vitro studies demonstrated a failure in cholesterol transport from chylomicrons.
- The precise biochemical defect underlying the lipid abnormality was not definitively identified.
Implications:
- Sea-blue histiocytes may serve as a clinical marker for certain types of abnormal lipid metabolism.
- This case underscores the complex interplay between cellular morphology and metabolic disorders.
- Further research is warranted to elucidate the specific mechanisms of lipid transport defects associated with SBH.